Apoptosis is the primary means by which most radio- and chemotherapy modali
ties kill cancer cells, and abnormalities in the apoptotic pathways may con
tribute to disease pathogenesis of cancer. Multiple Myeloma (MM) is a hemat
ological malignancy which will affect 14,000 new individuals in the United
States in 2001 and remains irreversibly fatal despite all available therapi
es. The current review focuses on the studies of apoptotic and survival sig
naling pathways in MM cells, which have both identified novel apoptotic and
anti-apoptotic proteins and provided targets for novel therapeutics.